Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Hypertension and cardiovascular remodelling in rats exposed to continuous light: protection by ACE-inhibition and melatonin

F. Simko, O. Pechanova, K. Repova Bednarova, K. Krajcirovicova, P. Celec, N. Kamodyova, S. Zorad, J. Kucharska, A. Gvozdjakova, M. Adamcova, L. Paulis,

. 2014 ; 2014 (-) : 703175.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc15023153

Exposure of rats to continuous light attenuates melatonin production and results in hypertension development. This study investigated whether hypertension induced by continuous light (24 hours/day) exposure induces heart and aorta remodelling and if these alterations are prevented by melatonin or angiotensin converting enzyme inhibitor captopril. Four groups of 3-month-old male Wistar rats (10 per group) were treated as follows for six weeks: untreated controls, exposed to continuous light, light-exposed, and treated with either captopril (100 mg/kg/day) or melatonin (10 mg/kg/day). Exposure to continuous light led to hypertension, left ventricular (LV) hypertrophy and fibrosis, and enhancement of the oxidative load in the LV and aorta. Increase in systolic blood pressure by continuous light exposure was prevented completely by captopril and partially by melatonin. Both captopril and melatonin reduced the wall thickness and cross-sectional area of the aorta and reduced the level of oxidative stress. However, only captopril reduced LV hypertrophy development and only melatonin reduced LV hydroxyproline concentration in insoluble and total collagen in rats exposed to continuous light. In conclusion, captopril prevented LV hypertrophy development in the continuous light-induced hypertension model, while only melatonin significantly reduced fibrosis. This antifibrotic action of melatonin may be protective in hypertensive heart disease.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15023153
003      
CZ-PrNML
005      
20231121102500.0
007      
ta
008      
150709s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2014/703175 $2 doi
035    __
$a (PubMed)25110398
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Simko, Fedor $u Department of Pathophysiology, School of Medicine, Comenius University, Sasinkova 4, 81372 Bratislava, Slovakia ; 3rd Clinic of Medicine, School of Medicine, Comenius University, 83305 Bratislava, Slovakia ; Institute of Experimental Endocrinology, Slovak Academy of Sciences, 83305 Bratislava, Slovakia ; Center of Excellence NOREG, 81372 Bratislava, Slovakia.
245    10
$a Hypertension and cardiovascular remodelling in rats exposed to continuous light: protection by ACE-inhibition and melatonin / $c F. Simko, O. Pechanova, K. Repova Bednarova, K. Krajcirovicova, P. Celec, N. Kamodyova, S. Zorad, J. Kucharska, A. Gvozdjakova, M. Adamcova, L. Paulis,
520    9_
$a Exposure of rats to continuous light attenuates melatonin production and results in hypertension development. This study investigated whether hypertension induced by continuous light (24 hours/day) exposure induces heart and aorta remodelling and if these alterations are prevented by melatonin or angiotensin converting enzyme inhibitor captopril. Four groups of 3-month-old male Wistar rats (10 per group) were treated as follows for six weeks: untreated controls, exposed to continuous light, light-exposed, and treated with either captopril (100 mg/kg/day) or melatonin (10 mg/kg/day). Exposure to continuous light led to hypertension, left ventricular (LV) hypertrophy and fibrosis, and enhancement of the oxidative load in the LV and aorta. Increase in systolic blood pressure by continuous light exposure was prevented completely by captopril and partially by melatonin. Both captopril and melatonin reduced the wall thickness and cross-sectional area of the aorta and reduced the level of oxidative stress. However, only captopril reduced LV hypertrophy development and only melatonin reduced LV hydroxyproline concentration in insoluble and total collagen in rats exposed to continuous light. In conclusion, captopril prevented LV hypertrophy development in the continuous light-induced hypertension model, while only melatonin significantly reduced fibrosis. This antifibrotic action of melatonin may be protective in hypertensive heart disease.
650    _2
$a inhibitory ACE $x terapeutické užití $7 D000806
650    _2
$a zvířata $7 D000818
650    _2
$a antihypertenziva $x terapeutické užití $7 D000959
650    _2
$a krevní tlak $x účinky léků $7 D001794
650    _2
$a kaptopril $x terapeutické užití $7 D002216
650    _2
$a hypertenze $x farmakoterapie $7 D006973
650    12
$a světlo $7 D008027
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a melatonin $x terapeutické užití $7 D008550
650    _2
$a oxidační stres $x účinky léků $7 D018384
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pechanova, Olga $u Center of Excellence NOREG, 81372 Bratislava, Slovakia ; Institute of Normal and Pathological Physiology, Slovak Academy of Sciences, 81371 Bratislava, Slovakia.
700    1_
$a Repova Bednarova, Kristina $u Department of Pathophysiology, School of Medicine, Comenius University, Sasinkova 4, 81372 Bratislava, Slovakia.
700    1_
$a Krajcirovicova, Kristina $u Department of Pathophysiology, School of Medicine, Comenius University, Sasinkova 4, 81372 Bratislava, Slovakia.
700    1_
$a Celec, Peter $u Department of Pathophysiology, School of Medicine, Comenius University, Sasinkova 4, 81372 Bratislava, Slovakia ; Institute of Molecular Biomedicine, School of Medicine, Comenius University, 81372 Bratislava, Slovakia.
700    1_
$a Kamodyova, Natalia $u Institute of Molecular Biomedicine, School of Medicine, Comenius University, 81372 Bratislava, Slovakia.
700    1_
$a Zorad, Štefan, $d 1956- $u Institute of Experimental Endocrinology, Slovak Academy of Sciences, 83305 Bratislava, Slovakia ; Center of Excellence NOREG, 81372 Bratislava, Slovakia. $7 xx0310348
700    1_
$a Kucharska, Jarmila $u 3rd Clinic of Medicine, School of Medicine, Comenius University, 83305 Bratislava, Slovakia.
700    1_
$a Gvozdjakova, Anna $u 3rd Clinic of Medicine, School of Medicine, Comenius University, 83305 Bratislava, Slovakia.
700    1_
$a Adamcova, Michaela $u Department of Physiology, School of Medicine, Charles University, 50038 Hradec Kralove 1, Czech Republic. $7 gn_A_00001180
700    1_
$a Paulis, Ludovit $u Department of Pathophysiology, School of Medicine, Comenius University, Sasinkova 4, 81372 Bratislava, Slovakia ; Center of Excellence NOREG, 81372 Bratislava, Slovakia.
773    0_
$w MED00006378 $t Mediators of inflammation $x 1466-1861 $g Roč. 2014, č. - (2014), s. 703175
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25110398 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20231121102457 $b ABA008
999    __
$a ok $b bmc $g 1083491 $s 906146
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 2014 $c - $d 703175 $i 1466-1861 $m Mediators of inflammation $n Mediators Inflamm $x MED00006378
LZP    __
$a Pubmed-20150709

Find record

Citation metrics

Archiving options